SpringTide Ventures
VC Fund
Cambridge, United States
SpringTide Ventures is a VC fund in Cambridge focused on Health Care and Medical. SpringTide is a venture capital that provides investment in the health tech industry. The firm was founded in 2018 and is headquartered in Cambridge, Massachusetts, United States.
- Total investments:
- 48
- Last investment:
- Lead investor:
- 33%
- Fund size:
- $65M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries SpringTide Ventures invests in
Stages SpringTide Ventures invests in
Countries SpringTide Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.5M–$9.3M
- Series A
- $2.1M–$15M
Investment Focus
Industry
- Health Care 22 (46%)
- Medical 14 (29%)
- Software 6 (13%)
- Information Technology 5 (10%)
- Biotechnology 4 (8%)
Stage
- Seed 19 (40%)
- Series A 9 (19%)
- Funding Round 5 (10%)
- Series B 2 (4%)
- Series C 2 (4%)
Country
- United States 28 (58%)
- Israel 1 (2%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Austin Walters
Co-Founder, Managing Partner, Investment Committee Member
|
Co-Founder, Managing Partner, Investment Committee Member | Total investments: 29 | Find email | |
|
Brad Otto
Principal
|
Principal | Total investments: 3 | Find email | |
|
Andrea Paul
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
|
Daniel Lambert
Co-Founder, Investment Committee Member
|
Co-Founder, Investment Committee Member | Total investments: 0 | Find email | |
|
Daniel Lambert
Co-Founder, Investment Committee Member
|
Co-Founder, Investment Committee Member | Total investments: 1 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Dopl Technologies develops remote robotic ultrasound systems that combine robotics, telepresence, and AI to expand access to diagnostic imaging. Its platform enables healthcare providers to perform ultrasound examinations remotely, helping hospitals and clinics address workforce shortages and improve access to imaging services. The company focuseson diagnostic imaging solutions for rural and underserved healthcare settings. | $6.3M / Seed / Jul 27, 2026 | |
|
|
Tava Health provides digital mental health services that connect individuals with licensed therapists through an online platform. The company offers therapy sessions via video, along with tools for scheduling, communication, and care coordination. Its services are structured to support employers and organizations in delivering mental healthbenefits to their members or employees. The platform includes features for matching users with therapists based on preferences and clinical needs. Tava Health also provides administrative support and reporting tools to help organizations manage utilization and access to care. | $40M / Series C / Apr 21, 2026 | |
|
|
WearLinq is a provider of wearable health monitoring and diagnosis solutions. The company's device records a multi-lead ECG and transmits it in real-time with AI to detect typical irregular heart rhythms, including a normal heart rhythm, aFib, bradycardia, and tachycardia, allowing users to discover history and trends, set reminders, andconnect directly with physicians. | $14M / Series A / Dec 17, 2025 | |
|
|
Ignite is the UK’s leading provider of technology-driven Patient Recruitment and Real-World Evidence solutions. | $10.9M / Series A / Aug 14, 2025 | |
|
|
Paterna Biosciences is an early-stage biotechnology startup that focuses on male reproductive health at the cellular level. The company aims to engage men in optimizing their reproductive and offspring health and establish a balanced fertility market, enabling clinics to solve both male and female challenges. | $6.4M / Seed / Oct 28, 2024 | |
|
|
Leash Biosciences engages in machine learning to solve medicinal chemistry. | $9.3M / Seed / Apr 05, 2024 | |
|
|
Leash Biosciences engages in machine learning to solve medicinal chemistry. | $9.3M / Seed / Apr 05, 2024 | |
|
|
Aegle Health Partners provides risk management services to revolutionize stop-loss reinsurance for health payers and companies. Aegle Health Partners model provides similar effective tail protection as traditional reinsurance (e.g., stop-loss) but for 25%+ less, without lasers or exclusions, and with full upfront population health credit. | Series A / Apr 01, 2024 | |
|
|
Nest Health offers medical services that aim to minimize the stress of arranging childcare, making travel arrangements, and leaving home. The company offers a wide range of services to newborns, babies, children, teens, and adults for medical, behavioral, nutrition, and more, enabling patients to get treated at home. | $4M / Seed / Mar 11, 2024 | |
|
|
Tava Health provides digital mental health services that connect individuals with licensed therapists through an online platform. The company offers therapy sessions via video, along with tools for scheduling, communication, and care coordination. Its services are structured to support employers and organizations in delivering mental healthbenefits to their members or employees. The platform includes features for matching users with therapists based on preferences and clinical needs. Tava Health also provides administrative support and reporting tools to help organizations manage utilization and access to care. | $20M / Series B / Dec 29, 2023 | |
| See all 48 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does SpringTide Ventures invest in?
SpringTide Ventures invests primarily in Health Care, Medical and Software startups, most often at Seed and Series A stage. Most of the 48 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is SpringTide Ventures's check size?
SpringTide Ventures typically joins rounds of $1.5M–$9.3M at Seed and $2.1M–$15M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SpringTide Ventures participates in.
How do I contact SpringTide Ventures?
Public channels for SpringTide Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SpringTide Ventures?
The team at SpringTide Ventures includes Austin Walters (Co-Founder, Managing Partner, Investment Committee Member), Brad Otto (Principal) and Andrea Paul (Venture Partner), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!